Full Text View
Tabular View
No Study Results Posted
Related Studies
Fatty Acid Oxidation Disorders & Body Weight Regulation Grant
This study is currently recruiting participants.
Verified by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), April 2009
First Received: April 3, 2008   Last Updated: April 21, 2009   History of Changes
Sponsors and Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Oregon State University
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00654004
  Purpose

Several hormones involved in body weight regulation increase our ability to burn fat for energy. The purpose of this study is to investigate how burning fat for energy may affect those hormones and body weight in children.

The study will also determine if eating a diet higher in protein alters the amount of fat you burn and how these hormones control body weight.


Condition Intervention
Trifunctional Protein Deficiency
Other: Dietary intervention

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Subject), Active Control, Parallel Assignment
Official Title: Fatty Acid Oxidation Disorders & Body Weight Regulation

Resource links provided by NLM:


Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • The primary outcome of this study is the difference in percent body fat (%BF) between subjects with a long-chain fatty acid oxidation disorder and normal controls. [ Time Frame: December 2009 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The secondary outcome of this study is the difference in weight gain between subjects with TFP and VLCAD deficiency consuming a high protein compared to a high carbohydrate diet for four months. [ Time Frame: December 2009 ] [ Designated as safety issue: No ]

Estimated Enrollment: 48
Study Start Date: April 2006
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Dietary intervention
    Subjects with trifunctional protein (TFP) or very long-chain acyl-CoA dehyrogenase (VLCAD) deficiency will be assigned to 4-months of increased protein, reduced carbohydrate diet or 4-months of current treatment with a high carbohydrate diet. The effect of MCT supplementation immediately prior to exercise will also be assessed in a randomized design.
Detailed Description:

A role for mitochondrial fatty acid oxidation in the peripheral signaling cascade of leptin, adiponectin and insulin has recently been proposed from animal studies but has not been investigated in humans. Children with trifunctional protein (TFP, including deficiency of long-chain hydroxyacyl-CoA dehydrogenase) and very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, inherited disorders of long-chain fatty acid ß-oxidation, lack an ability to oxidize fatty acids for energy. They have increased levels of body fat and circulating leptin and a high incidence of obesity. Current therapy for children with these disorders is based on frequent meals and consuming a low fat, very high carbohydrate diet. Despite treatment, exercise induced rhabdomyolysis is a common complication of TFP and VLCAD deficiency that frequently leads to exercise avoidance. The effects of these genetic defects on body composition and weight regulation have not been investigated. The contribution of fatty-acid oxidation during moderate intensity exercise in children has also not been reported.

We propose to study peripheral signals of body weight regulation, body composition, and exercise metabolism in children with TFP and VLCAD deficiency compared to normal controls. We also propose to determine the effects of a long-term increased protein, low fat diet on body composition, and weight regulation in children with long-chain fatty acid oxidation disorders.

  Eligibility

Ages Eligible for Study:   7 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • confirmed diagnosis of TFP, LCHAD or VLCAD deficiency
  • at least 7 years of age
  • willingness to complete overnight admission
  • generally healthy

Exclusion Criteria:

  • inclusion in another research project that alters macronutrient intake
  • diabetes, thyroid disease or other endocrine dysfunction that alters body composition.
  • pregnancy
  • anemia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00654004

Contacts
Contact: Melanie B. Gillingham, PhD 503-494-1682 gillingm@ohsu.edu
Contact: Stacey M. LaVoie 503-494-2417 lavoies@ohsu.edu

Locations
United States, Oregon
Oregon Health & Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Melanie B. Gillingham, PhD     503-494-1682     gillingm@ohsu.edu    
Sponsors and Collaborators
Oregon State University
Investigators
Principal Investigator: Melanie B. Gillingham, PhD Oregon Health and Science University
  More Information

No publications provided

Responsible Party: Oregon Health & Science University ( Melanie Gillingham, PhD )
Study ID Numbers: DK71869
Study First Received: April 3, 2008
Last Updated: April 21, 2009
ClinicalTrials.gov Identifier: NCT00654004     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
trifunctional
protein
deficiency
TFP
weight
regulation

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
LCHAD Deficiency
Malnutrition
Protein Deficiency
Mitochondrial Trifunctional Protein Deficiency
Nutrition Disorders
Deficiency Diseases

Additional relevant MeSH terms:
Body Weight
Signs and Symptoms
Malnutrition
Protein Deficiency
Nutrition Disorders
Deficiency Diseases

ClinicalTrials.gov processed this record on September 09, 2009